Technology Showcase:
ADC Conjugation Chemistry
ADC Conjugation Chemistry
19 February 2026 | Online, GMT (UTC+0)
SPONSORED BY

Interest in ADCs has surged in recent years. With 13 FDA-approved therapies and billions of dollars invested in the field, biologics manufacturers must stay focused and avoid getting caught up in the hype.
Join us to explore the latest advances in ADC bioconjugation chemistry, including how enhanced linker technologies can be optimised, the expansion of potential targets, and the use of deep learning for ADC prediction. Witness cutting-edge technologies in action and join a live expert discussion.
- Discover Cutting-Edge ADC Bioconjugation Strategies – Learn how enhanced linker technologies and an expanded pool of targets are advancing the design of next-generation ADCs.
- See Innovative Technologies in Action – Explore how deep learning and other computational approaches are transforming ADC prediction and optimisation.
- Connect Live with Experts – Engage directly with leading scientists, solution providers, and thought leaders shaping the future of ADC development.
This is your chance to see the latest tools in action, understand their real-world impact, and leave with practical takeaways to apply in your own research.
VPs, Directors & Senior Managers from leading pharma & biotech companies and research institutions in the following fields and more:
- ADC Discovery
- Payload/Linker Chemistry
- Bioconjugation
- Antibody Discovery
- Antibody Engineering
- ADC Development
60-Minute Agenda
14:00 - 14:15
Industry Presentation: An Unconventional ADC Company Thinking About Cancer Differently
Presentation Recording
MIKE SHOPPERLE
Chief Executive Officer, CureMeta
14:15 – 14:30
Industry Presentation: ADCPedia. A Deep Learning Approach For ADC Prediction
Presentation Recording
VICTOR JEFFREY LEYTON
Associate Professor, University Of Ottawa
14:30 – 14:45
Solution Provider Presentation
For sponsorship opportunities please contact: sponsorship@oxfordglobal.com
14:45 – 15:00
See The Technology In Action + Live Q&A
15:00
